Pine River Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Pine River Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-5,584	Closed	-$1.27M	–	712
2013 Q3	$1.27M	Sell	5,584 -12,599	-69%	-$2.2M	0.01%	385
2013 Q2	$2.56M	Buy	+18,183	New	+$2.88M	0.04%	302

Other funds holding TTPH

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

FV2GP

Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM

AWMDMG

Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return

Pine River Capital Management's TTPH Position: Q4 2013 in Review

Pine River Capital Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2013, closing a stake of 5,584 shares — an estimated $1.27M sold.

Pine River Capital Management first reported a position in TTPH in Q2 2013 and held it in 2 quarters. The position peaked at $2.56M in Q2 2013. 54 funds tracked by Wall St. Rank hold TTPH as of Q4 2013.

Pine River Capital Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2013 after selling out during the quarter.
Pine River Capital Management sold 5,584 Tetraphase Pharmaceuticals, Inc. shares in Q4 2013, an estimated $1.27M.
Pine River Capital Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 2 quarters.
Pine River Capital Management's Tetraphase Pharmaceuticals, Inc. position peaked at $2.56M in Q2 2013.
54 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2013.

Based on Pine River Capital Management's 13F filing for Q4 2013, filed 13 Feb 2014.